A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
SURFACEN ® inhibits the growth of bacteria causing respiratory infections
2005
Biotecnología Aplicada
unpublished
Preserved Fulltext
One pharmaceutical preparation of exogenous lung surfactant, SURFACEN ® , was tested in vitro on growth of pathogens involved in lung disease. SURFACEN ® at concentration of 1, 10 and 20 mg/mL was incubated with Streptococcus pneumoniae, Streptococcus agalactiae, Staphylococcus aureus, Klebsiella pneumoniae and Escheri-chia coli in saline solution by 5 h at 37 °C. In the presence of SURFACEN ® it was observed a decrease of colony forming units in all evaluated concentrations and from 10 mg/mL a
fatcat:xlonimzcxngqrbhtceds3c6hze